Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients
- PMID: 18187094
- DOI: 10.1016/j.healun.2007.09.027
Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients
Abstract
Background: Post-transplant lymphoproliferative disease (PTLD) is a severe complication in transplant recipients. Detection of increased Epstein-Barr viral (EBV) load in the peripheral blood acts as a surrogate marker for increased risk of PTLD development. We prospectively monitored EBV load, immunosuppression and PTLD in pediatric heart transplant (HTx) patients to determine risk factors for an increased EBV load and risk of PTLD.
Methods: Forty-one pediatric heart transplant recipients were included and underwent prospective monitoring of their immunosuppression and ethylene-diamine tetraacetic acid (EDTA) blood sampling for EBV load (copies/microg DNA) measurement using quantitative real-time polymerase chain reaction (PCR; TaqMan) during January 2001 to December 2006.
Results: EBV load was measurable in 70% and was significantly increased (>2,000 copies/microg DNA) in 35% of the patients, with a median EBV load of 5,100 (range 0 to 50,665 copies/microg DNA). Increased EBV load was detected in patients receiving CsA-azathioprine or more than two doses of anti-thymocyte globulin (ATG) and in those <10 years of age, without any significant differences in CsA blood levels. Lowest or negative EBV load was measured in patients receiving CsA-mycophenolate mofetil (MMF) or CsA only. CsA blood levels were not predictable for increased EBV load or PTLD. Six patients developed a EBV-associated B-cell lymphoma (PTLD), among whom 4 (67%) were receiving CsA-azathioprine.
Conclusions: Frequent EBV load monitoring identifies patients at high risk for PTLD development. Azathioprine and ATG are major risk factors for increased EBV load and PTLD and patients may benefit from a change of immunosuppression in addition to pre-emptive anti-viral or anti-tumor strategies.
Similar articles
-
Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.Transpl Int. 2008 Oct;21(10):963-71. doi: 10.1111/j.1432-2277.2008.00709.x. Epub 2008 Jun 24. Transpl Int. 2008. PMID: 18564989
-
[Epstein Barr viral load monitoring in mononuclear lymphocytes and serum of renal transplant recipients using a quantitative PCR protocol].G Ital Nefrol. 2003 Mar-Apr;20(2):170-5. G Ital Nefrol. 2003. PMID: 12746803 Italian.
-
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26. Transpl Infect Dis. 2009. PMID: 19497070
-
[Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].Nefrologia. 2002;22(5):463-9. Nefrologia. 2002. PMID: 12497748 Review. Spanish.
-
Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.Transpl Int. 2007 Mar;20(3):207-18. doi: 10.1111/j.1432-2277.2006.00416.x. Transpl Int. 2007. PMID: 17291214 Review.
Cited by
-
Growth Transformation of B Cells by Epstein-Barr Virus Requires IMPDH2 Induction and Nucleolar Hypertrophy.Microbiol Spectr. 2023 Aug 17;11(4):e0044023. doi: 10.1128/spectrum.00440-23. Epub 2023 Jul 6. Microbiol Spectr. 2023. PMID: 37409959 Free PMC article.
-
Early experience with pediatric cardiac transplantation in a limited resource setting.Ann Pediatr Cardiol. 2020 Jul-Sep;13(3):220-226. doi: 10.4103/apc.APC_105_19. Epub 2020 Jul 2. Ann Pediatr Cardiol. 2020. PMID: 32863657 Free PMC article.
-
Post Transplant Lymphoproliferative Disorder.Indian J Hematol Blood Transfus. 2020 Apr;36(2):229-237. doi: 10.1007/s12288-019-01182-x. Epub 2019 Sep 17. Indian J Hematol Blood Transfus. 2020. PMID: 32425371 Free PMC article. Review.
-
Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.World J Gastroenterol. 2017 Feb 21;23(7):1224-1232. doi: 10.3748/wjg.v23.i7.1224. World J Gastroenterol. 2017. PMID: 28275302 Free PMC article.
-
A Proposal for Early Dosing Regimens in Heart Transplant Patients Receiving Thymoglobulin and Calcineurin Inhibition.Transplant Direct. 2016 May 20;2(6):e81. doi: 10.1097/TXD.0000000000000594. eCollection 2016 Jun. Transplant Direct. 2016. PMID: 27500271 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical